Financials
- Market Capitalization 8.75 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-3 449
市销率
5.56
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 959 | AXSM Axsome Therapeutics, Inc. - Common Stock | 169.03 USD | +0.40% | -4.67% | -23.84% | +29.82% | 8.85 B USD | ||
| 965 | CYTK Cytokinetics, Incorporated - Common Stock | 62.93 USD | +0.03% | -2.04% | -14.39% | +8.31% | 8.75 B USD | ||
| 982 | TGTX TG Therapeutics, Inc. - Common Stock | 55.44 USD | +0.13% | +2.48% | +2.72% | +64.66% | 8.49 B USD | ||
| 1044 | SYRE Spyre Therapeutics, Inc. - Common Stock | 85.16 USD | -0.62% | -7.98% | -6.00% | +256.17% | 7.51 B USD |